173 related articles for article (PubMed ID: 18422031)
1. A very rare cause of virilization in childhood: ovarian Leydig cell tumor.
Arhan E; Cetinkaya E; Aycan Z; Aslan AT; Yücel H; Vidinlisan S
J Pediatr Endocrinol Metab; 2008 Feb; 21(2):181-3. PubMed ID: 18422031
[TBL] [Abstract][Full Text] [Related]
2. A rare ovarian Leydig cell tumor (hilar type) causing virilization in a postmenopausal woman.
Vouza E; Kairi-Vassilatou E; Kleanthis CK; Hasiakos N; Salakos N; Kondi-Pafiti A
Eur J Gynaecol Oncol; 2011; 32(5):557-9. PubMed ID: 22053675
[TBL] [Abstract][Full Text] [Related]
3. Bilateral Leydig cell tumour of the ovary: a rare cause of virilization in postmenopausal patient.
Sanz OA; Martinez PR; Guarch RT; Goñi MJ; Alcazar JL
Maturitas; 2007 Jun; 57(2):214-6. PubMed ID: 17289310
[TBL] [Abstract][Full Text] [Related]
4. Hyperandrogenism caused by ovarian Leydig cell tumour: finding the needle in a haystack.
Tong CV; Tai YT
BMJ Case Rep; 2020 Dec; 13(12):. PubMed ID: 33318251
[TBL] [Abstract][Full Text] [Related]
5. Ovarian Leydig cell tumor in a post-menopausal patient with severe hyperandrogenism.
Souto SB; Baptista PV; Braga DC; Carvalho D
Arq Bras Endocrinol Metabol; 2014 Feb; 58(1):68-75. PubMed ID: 24728167
[TBL] [Abstract][Full Text] [Related]
6. New-Onset Type 2 Diabetes and Virilization in a Benign Sex Cord Tumor.
Feiz F; Tehranian A; Heidary SS; Seifollahi A
J Coll Physicians Surg Pak; 2016 Nov; 26(11):S89-S91. PubMed ID: 28666491
[TBL] [Abstract][Full Text] [Related]
7. Ovarian tumors secreting androgens: an infrequent cause of hyperandrogenism.
Perez Lana M; Demayo S; Monastero A; Nolting M
Minerva Ginecol; 2019 Feb; 71(1):72-77. PubMed ID: 30291701
[TBL] [Abstract][Full Text] [Related]
8. Virilizing ovarian hilus (Leydig) cell tumor with concurrent contralateral hilus cell hyperplasia: a rare diagnosis.
Zafrakas M; Venizelos ID; Theodoridis TD; Zepiridis L; Agorastos T; Bontis JN
Eur J Gynaecol Oncol; 2009; 30(3):338-40. PubMed ID: 19697637
[TBL] [Abstract][Full Text] [Related]
9. Virilization due to androgen hypersecretion in a patient with ovarian leydig cell tumor: diagnostic and psychosocial implications.
Juniarto AZ; Setiawati BA; Ediati A; van der Zwan YG; Looijenga LH; de Jong FH; Dessens A; Drop SL; Faradz SM
Acta Med Indones; 2013 Apr; 45(2):130-5. PubMed ID: 23770793
[TBL] [Abstract][Full Text] [Related]
10. Ovarian steroid cell tumor and a contralateral ovarian thecoma in a postmenopausal woman with severe hyperandrogenism.
Cserepes E; Szücs N; Patkós P; Csapó Z; Molnár F; Tóth M; Dabasi G; Esik O; Rácz K
Gynecol Endocrinol; 2002 Jun; 16(3):213-6. PubMed ID: 12192893
[TBL] [Abstract][Full Text] [Related]
11. Intraoperative venous blood sampling to localize a small androgen-producing ovarian tumor.
Bohlmann MK; Rabe T; Sinn HP; Strowitzki T; Von Wolff M
Gynecol Endocrinol; 2005 Sep; 21(3):138-41. PubMed ID: 16335905
[TBL] [Abstract][Full Text] [Related]
12. Pure Leydig cell tumour (hilus cell) of the ovary: a rare cause of virilization after menopause.
Baiocchi G; Manci N; Angeletti G; Celleno R; Fratini D; Gilardi G
Gynecol Obstet Invest; 1997; 44(2):141-4. PubMed ID: 9286731
[TBL] [Abstract][Full Text] [Related]
13. Agnogenic myeloid metaplasia in an ovarian steroid cell tumor with virilization: a case report.
Huang CW; Hsueh S; Chang MY
J Reprod Med; 2004 Sep; 49(9):765-8. PubMed ID: 15493572
[TBL] [Abstract][Full Text] [Related]
14. [Sertoli-Leydig-cell ovarian tumor with a retiform pattern and heterologous elements: a rare cause of virilization].
García Pascual IJ; Corrales Hernández JJ; Miralles García JM; García Díez LC; Villabona Sánchez V; Serrano de Dios E
Rev Clin Esp; 1992 Mar; 190(4):191-4. PubMed ID: 1589616
[TBL] [Abstract][Full Text] [Related]
15. [Sertoli-Leydig tumors in children. 2 case reports].
Mariani R; Taleb-Figueroa A; Bastiani-Griffet F; Monpoux F; Coussement A; Loubière R
Ann Pediatr (Paris); 1993 Sep; 40(7):438-43. PubMed ID: 8239395
[TBL] [Abstract][Full Text] [Related]
16. Confounder factors masking a Leydig-cell ovarian tumor in a post-menopausal woman treated for androgen-positive receptor breast cancer.
Moura FS; Costa-Barbosa FA; Leao SC; Nicolau SM; Kater CE; Monteagudo PT
Gynecol Endocrinol; 2017 Sep; 33(9):675-679. PubMed ID: 28443693
[TBL] [Abstract][Full Text] [Related]
17. [Ovarian Leydig cell tumor].
Tönnies P; Mlynek-Kersjes ML; Gellén J; Watermann D
Zentralbl Gynakol; 1997; 119(5):241-5. PubMed ID: 9281260
[TBL] [Abstract][Full Text] [Related]
18. Occult symptomatic bilateral pure Leydig cell tumors in a postmenopausal woman: a case report.
Hussain SA; Dubil EA; De Luca-Johnson JN; Johnston M
Gynecol Endocrinol; 2021 Jul; 37(7):672-675. PubMed ID: 34137345
[TBL] [Abstract][Full Text] [Related]
19. Ovarian Leydig cell tumor in a peri-menopausal woman with severe hyperandrogenism and virilization.
Nardo LG; Ray DW; Laing I; Williams C; McVey RJ; Seif MW
Gynecol Endocrinol; 2005 Oct; 21(4):238-41. PubMed ID: 16316848
[TBL] [Abstract][Full Text] [Related]
20. "Occult" ovarian Leydig cell tumor: when laboratory tells more than imaging.
Paragliola RM; Torino F; Senes P; Castellino L; Salutari V; Pontecorvi A; Scambia G; Corsello SM
Endocrine; 2014 Jun; 46(2):351-4. PubMed ID: 24091542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
